Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 28, 2026 18:07 ET | Source: Interparfums, Inc.

Interparfums, Inc. Announces Exclusive Worldwide License Agreement With Nautica

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that it has entered into an exclusive, 20-year worldwide license...
January 28, 2026 18:06 ET | Source: Interparfums, Inc.

Interparfums, Inc. Announces Exclusive Worldwide License Agreement with David Beckham

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that it has entered into an exclusive, 20-year worldwide license...
January 28, 2026 08:01 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use

60 Degrees Pharma licenses FSU technology to purify castanospermine and begins U.S. regulatory steps for non-Rx Australian Chestnut Extract.
January 28, 2026 07:00 ET | Source: Seamless Therapeutics

Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss

Seamless Therapeutics announces research collaboration and licensing agreement with Eli Lilly for gene therapy for genetic hearing disorders
January 27, 2026 11:59 ET | Source: Ofinno

Ofinno Hires Arvind Jairam as Director of Patent Licensing and Acquisitions

Reston, VA, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ofinno, a global leader in wireless and media standards, today announced that Arvind Jairam has joined the company as Director of Patent Licensing and...
January 27, 2026 08:00 ET | Source: Lisata Therapeutics, Inc.

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

BASKING RIDGE, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
January 26, 2026 09:00 ET | Source: Galaxy Gaming, Inc.

Galaxy Gaming® and Hasbro® Launch MONOPOLY® Blackjack Progressive Across Metropolitan Casinos in the UK

Galaxy Gaming and Hasbro launch MONOPOLY Blackjack Progressive in the UK, debuting at leading Metropolitan Casinos
January 26, 2026 08:00 ET | Source: Genyro

Genyro Signs Exclusive License for “Sidewinder,” a Breakthrough DNA Construction Technology Featured in Nature

SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Genyro Inc., a biotechnology company advancing next-generation DNA construction, today announced that it has entered into an exclusive licensing...
January 23, 2026 15:23 ET | Source: Zynova Tech Ltd

Zynova Tech Launches the Title Industry’s First Automated Workshare Platform for Compliant, Multi-Jurisdictional Order Flow

Atlanta, Georgia, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Zynova Tech LLC today launched Zynova.ai, the first-of-its-kind proprietary workshare platform in the title insurance industry, specifically...
January 20, 2026 04:00 ET | Source: smartbax GmbH

smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris

Munich, Germany, Jan. 20, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the in-licensing of a new...